The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Oct 2018
Randomized Controlled TrialDeterminants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
Adverse effects on reproductive function are a key concern in young women treated with chemotherapy for advanced Hodgkin's lymphoma. We aimed to identify risk factors for the extent of ovarian damage in women with Hodgkin's lymphoma treated with different chemotherapy regimens to inform accurate advice on options for fertility preservation. ⋯ Medical Research Foundation and Cancer Research UK.